GlassScriptPhysician profile
Lonny Nodelman
NPI 1891058921
$2,741.78
in general payments reported to CMS, 2019-2025
11 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,276 · 2022: $1,225 · 2023: $58.36 · 2024: $36.53 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $2,423.01 | 2021-2025 | |
| Smith+Nephew, INC. | $83.96 | 2023-2025 | Grafix, Stravix, Renasys Go V2 Home |
| Misonix INC | $41.96 | 2021 | |
| Reapplix INC. | $36.53 | 2023-2025 | 3c Patch Kit - Box |
| Stryker Corporation | $36.53 | 2024 | Flexband |
| Organogenesis INC. | $27.04 | 2021 | |
| Bioventus LLC | $24.92 | 2022 | |
| Paratek Pharmaceuticals, INC. | $23.10 | 2023 | Nuzyra |
| Reprise Biomedical, INC. | $20.40 | 2025 | Miro3d |
| Flower Orthopedics Coporation | $17.37 | 2025 | |
| Orthofix Medical, INC. | $6.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lonny Nodelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.